new device
new software
pharmacogenetics analysis
new diagnostic device-software combination
new diagnostic Nanostring-based device
lung samples
analysis of fusion genes
ALK
Lung cancEr fusiOn geNes
lung cancer patients
lung cancer treatment
technical feasibility analysis
throughput of biomarkers
secondary analysis of data
analysis of laboratory tests’ results
detection of
low throughput labs
ROS1
associated software
oncology business
clinical validation
Diatech Pharmacogenetics
time
European medium-high throughput labs
proprietary oncology EHR
existing standards
existing products
fusions detection
results standardization
clinical performance
Diatech PGx
potential customers
company’s approach of potential European distributors
specialized technical expertise
main variants of EML4
main scope of LEONID project
tyrosin kinase inhibitors
molecular pathology laboratories
predictive power of response
costs
development
hospitals
FISH
unknown partners
sensitivity
specificity
rearrangements
year
panel of features
experimental verification
standardized solution
error rate
IHC
hands
multiplex assay
end users
CE-IVD kit
robustness
reproducibility
personal interpretation
entrance
GeneticLab
BiMind